Er worden heel veel wetenschappelijke artikelen geschreven. Onderstaand een lijst met relevante artikelen op het gebied van cobalamine, achtergronden, studies, behandelaspecten, etc. De meeste van deze artikelen zijn in het public domain en te achterhalen / downloaden via de betreffende uitgever. Een goede bron om verder te zoeken naar andere referenties vormt PubMed: https://www.ncbi.nlm.nih.gov/pubmed/

  1. Healton EB, Savage DG, Brust JC, Garrett TJ, Lindenbaum J. Neurologic aspects of cobalamin deficiency. Medicine (Baltimore) 1991;70:229-45.
  2. Stabler SP. Clinical practice. Vitamin B12 deficiency. N Engl J Med 2013;368:149-60.
  3. Stone RE, Spies TD. Vitamin B12 and subacute combined degeneration of the spinal cord. Int Z Vitaminforsch Beih 1948;20:228-33.
  4. Zucker DK, Livingston RL, Nakra R, Clayton PJ. B12 deficiency and psychiatric disorders: case report and literature review. Biol Psychiatry 1981;16:197-205.
  5. Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Yoon JS. Predictive value of folate, vitamin B12 and homocysteine levels in late-life depression. Br J Psychiatry 2008;192:268-74.
  6. Oberlin BS, Tangney CC, Gustashaw KA, Rasmussen HE. Vitamin B12 deficiency in relation to functional disabilities. Nutrients 2013;5:4462-75.
  7. Hunt A, Harrington D, Robinson S. Vitamin B12 deficiency. BMJ 2014;349:g5226.
  8. Metz J. A high prevalence of biochemical evidence of vitamin B12 or folate deficiency does not translate into a comparable prevalence of anemia. Food Nutr Bull 2008;29:S74-85.
  9. den Elzen WP, Westendorp RG, Frolich M, de Ruijter W, Assendelft WJ, Gussekloo J. Vitamin B12 and folate and the risk of anemia in old age: the Leiden 85-Plus Study. Arch Intern Med 2008;168:2238-44.
  10. Yildirim T, Yalcin A, Atmis V, et al. The prevalence of anemia, iron, vitamin B12, and folic acid deficiencies in community dwelling elderly in Ankara, Turkey. Arch Gerontol Geriatr 2015;60:344-8.
  11. Solomon LR. Low Cobalamin Levels as Predictors of Cobalamin Deficiency: Importance of Comorbidities Associated with Increased Oxidative Stress. Am J Med 2016;129:115 e9- e16.
  12. Aparicio-Ugarriza R, Palacios G, Alder M, Gonzalez-Gross M. A review of the cut-off points for the diagnosis of vitamin B12 deficiency in the general population. Clin Chem Lab Med 2015;53:1149-59.
  13. Solomon LR. Cobalamin-responsive disorders in the ambulatory care setting: unreliability of cobalamin, methylmalonic acid, and homocysteine testing. Blood 2005;105:978-85; author reply 1137.
  14. Roessler FC, Wolff S. Rapid healing of a patient with dramatic subacute combined degeneration of spinal cord: a case report. BMC Res Notes 2017;10:18.
  15. Dobson R, Alvares D. The difficulties with vitamin B12. Pract Neurol 2016;16:308-11.
  16. Vugteveen I, Hoeksma M, Monsen AL, et al. Serum vitamin B12 concentrations within reference values do not exclude functional vitamin B12 deficiency in PKU patients of various ages. Mol Genet Metab 2011;102:13-7.
  17. Schrempf W, Eulitz M, Neumeister V, et al. Utility of measuring vitamin B12 and its active fraction, holotranscobalamin, in neurological vitamin B12 deficiency syndromes. J Neurol 2011;258:393-401.
  18. Herrmann W, Obeid R. Cobalamin deficiency. Subcell Biochem 2012;56:301-22.
  19. Vashi P, Edwin P, Popiel B, Lammersfeld C, Gupta D. Methylmalonic Acid and Homocysteine as Indicators of Vitamin B-12 Deficiency in Cancer. PloS one 2016;11:e0147843.
  20. Spence JD. Metabolic vitamin B12 deficiency: a missed opportunity to prevent dementia and stroke. Nutr Res 2016;36:109-16.
  21. Harrington DJ. Laboratory assessment of vitamin B12 status. J Clin Pathol 2017;70:168-73.
  22. Bailey RL, Durazo-Arvizu RA, Carmel R, et al. Modeling a methylmalonic acid-derived change point for serum vitamin B-12 for adults in NHANES. Am J Clin Nutr 2013;98:460-7.
  23. Iqbal N, Azar D, Yun YM, Ghausi O, Ix J, Fitzgerald RL. Serum methylmalonic acid and holotranscobalamin-II as markers for vitamin B12 deficiency in end-stage renal disease patients. Ann Clin Lab Sci 2013;43:243-9.
  24. Graber JJ, Sherman FT, Kaufmann H, Kolodny EH, Sathe S. Vitamin B12-responsive severe leukoencephalopathy and autonomic dysfunction in a patient with “normal” serum B12 levels. J Neurol Neurosurg Psychiatry 2010;81:1369-71.
  25. Nexo E, Hoffmann-Lucke E. Holotranscobalamin, a marker of vitamin B-12 status: analytical aspects and clinical utility. Am J Clin Nutr 2011;94:359S-65S.
  26. Heil SG, de Jonge R, de Rotte MC, et al. Screening for metabolic vitamin B12 deficiency by holotranscobalamin in patients suspected of vitamin B12 deficiency: a multicentre study. Ann Clin Biochem 2012;49:184-9.
  27. Herrmann W, Obeid R. Utility and limitations of biochemical markers of vitamin B12 deficiency. Eur J Clin Invest 2013;43:231-7.
  28. Devalia V. Diagnosing vitamin B-12 deficiency on the basis of serum B-12 assay. BMJ 2006;333:385-6.
  29. Hamilton MS, Blackmore S, Lee A. Possible cause of false normal B-12 assays. BMJ 2006;333:654-5.
  30. Yang DT, Cook RJ. Spurious elevations of vitamin B12 with pernicious anemia. N Engl J Med 2012;366:1742-3.
  31. Scarpa E, Candiotto L, Sartori R, Radossi P, Maschio N, Tagariello G. Undetected vitamin B12 deficiency due to false normal assay results. Blood Transfus 2013;11:627-9.
  32. Wainwright P, Narayanan S, Cook P. False-normal vitamin B12 results in a patient with pernicious anaemia. Clin Biochem 2015;48:1366-7.
  33. Dickinson CJ. Does folic acid harm people with vitamin B12 deficiency? QJM 1995;88:357-64.
  34. Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med 2004;350:2068-79.
  35. Van den Driessche A, Eenkhoorn V, Van Gaal L, De Block C. Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review. Neth J Med 2009;67:376-87.
  36. Michels AW, Gottlieb PA. Autoimmune polyglandular syndromes. Nature reviews Endocrinology 2010;6:270-7.
  37. Vrkljan AM, Pasalic A, Strinovic M, Peric B, Kruljac I, Mirosevc G. Coexistence of Addison’s Disease and Pernicious Anemia: Is the New Classification of Autoimmune Polyglandular Syndrome Appropriate? Acta Clin Croat 2015;54:232-5.
  38. Carmel R. Reassessment of the relative prevalences of antibodies to gastric parietal cell and to intrinsic factor in patients with pernicious anaemia: influence of patient age and race. Clin Exp Immunol 1992;89:74-7.
  39. Corcuff JB, Morel S, Georges A, de Bosredon K, Bordenave L. Do intrinsic factor antibodies assays provide univocal answers in Biermer’s disease? J Clin Lab Anal 2008;22:337-9.
  40. Berth M, Bonroy C, Guerti K, Uyttenbroeck W, Uytterhoeven M. Comparison of five commercially available ELISA kits for the determination of intrinsic factor antibodies in a vitamin B12 deficient adult population. Int J Lab Hematol 2016;38:e12-4.
  41. Khan S, Del-Duca C, Fenton E, et al. Limited value of testing for intrinsic factor antibodies with negative gastric parietal cell antibodies in pernicious anaemia. J Clin Pathol 2009;62:439-41.
  42. Nehra AK, Alexander JA, Loftus CG, Nehra V. Proton Pump Inhibitors: Review of Emerging Concerns. Mayo Clin Proc 2018;93:240-6.
  43. Pennypacker LC, Allen RH, Kelly JP, et al. High prevalence of cobalamin deficiency in elderly outpatients. J Am Geriatr Soc 1992;40:1197-204.
  44. Andres E, Affenberger S, Vinzio S, et al. Food-cobalamin malabsorption in elderly patients: clinical manifestations and treatment. Am J Med 2005;118:1154-9.
  45. Rizzo G, Lagana AS, Rapisarda AM, et al. Vitamin B12 among Vegetarians: Status, Assessment and Supplementation. Nutrients 2016;8.
  46. Parrott J, Frank L, Rabena R, Craggs-Dino L, Isom KA, Greiman L. American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the Surgical Weight Loss Patient 2016 Update: Micronutrients. Surg Obes Relat Dis 2017;13:727-41.
  47. Kornerup LS, Hvas CL, Abild CB, Richelsen B, Nexo E. Early changes in vitamin B12 uptake and biomarker status following Roux-en-Y gastric bypass and sleeve gastrectomy. Clin Nutr 2018.
  48. Smelt HJ, Smulders JF, Said M, Nienhuijs SW, Boer AK. Improving Bariatric Patient Aftercare Outcome by Improved Detection of a Functional Vitamin B12 Deficiency. Obes Surg 2016;26:1500-4.
  49. Morris N, Lynch K, Greenberg SA. Severe motor neuropathy or neuronopathy due to nitrous oxide toxicity after correction of vitamin B12 deficiency. Muscle Nerve 2015;51:614-6.
  50. Massey TH, Pickersgill TT, K JP. Nitrous oxide misuse and vitamin B12 deficiency. BMJ Case Rep 2016;2016.
  51. Buizert A, Sharma R, Koppen H. When the Laughing Stops: Subacute Combined Spinal Cord Degeneration Caused by Laughing Gas Use. J Addict Med 2017;11:235-6.
  52. Surendran S, Adaikalakoteswari A, Saravanan P, Shatwaan IA, Lovegrove JA, Vimaleswaran KS. An update on vitamin B12-related gene polymorphisms and B12 status. Genes Nutr 2018;13:2.
  53. Molloy AM. Should vitamin B12 status be considered in assessing risk of neural tube defects? Ann N Y Acad Sci 2018;1414:109-25.
  54. Rogne T, Tielemans MJ, Chong MF, et al. Associations of Maternal Vitamin B12 Concentration in Pregnancy With the Risks of Preterm Birth and Low Birth Weight: A Systematic Review and Meta-Analysis of Individual Participant Data. Am J Epidemiol 2017;185:212-23.
  55. Yajnik CS, Deshpande SS, Jackson AA, et al. Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia 2008;51:29-38.
  56. Krishnaveni GV, Hill JC, Veena SR, et al. Low plasma vitamin B12 in pregnancy is associated with gestational ‘diabesity’ and later diabetes. Diabetologia 2009;52:2350-8.
  57. Rush EC, Katre P, Yajnik CS. Vitamin B12: one carbon metabolism, fetal growth and programming for chronic disease. Eur J Clin Nutr 2014;68:2-7.
  58. Carmel R. Mild transcobalamin I (haptocorrin) deficiency and low serum cobalamin concentrations. Clin Chem 2003;49:1367-74.
  59. Farvid MS, Homayouni F, Amiri Z, Adelmanesh F. Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation. Diabetes Res Clin Pract 2011;93:86-94.
  60. Talaei A, Siavash M, Majidi H, Chehrei A. Vitamin B12 may be more effective than nortriptyline in improving painful diabetic neuropathy. Int J Food Sci Nutr 2009;60 Suppl 5:71-6.
  61. Sun Y, Lai MS, Lu CJ. Effectiveness of vitamin B12 on diabetic neuropathy: systematic review of clinical controlled trials. Acta Neurol Taiwan 2005;14:48-54.
  62. Jayabalan B, Low LL. Vitamin B supplementation for diabetic peripheral neuropathy. Singapore Med J 2016;57:55-9.
  63. Schloss JM, Colosimo M, Airey C, Vitetta L. Chemotherapy-induced peripheral neuropathy (CIPN) and vitamin B12 deficiency. Support Care Cancer 2015;23:1843-50.
  64. Schloss J, Colosimo M. B Vitamin Complex and Chemotherapy-Induced Peripheral Neuropathy. Curr Oncol Rep 2017;19:76.
  65. Zhang Y, Hodgson NW, Trivedi MS, et al. Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia. PloS one 2016;11:e0146797.
  66. Hendren RL, James SJ, Widjaja F, Lawton B, Rosenblatt A, Bent S. Randomized, Placebo-Controlled Trial of Methyl B12 for Children with Autism. J Child Adolesc Psychopharmacol 2016;26:774-83.
  67. NHG-standpunt Diagnostiek van vitamine-B12-deficiëntie.
  68. Vidal-Alaball J, Butler CC, Cannings-John R, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev 2005:CD004655.
  69. Kuzminski AM, Del Giacco EJ, Allen RH, Stabler SP, Lindenbaum J. Effective treatment of cobalamin deficiency with oral cobalamin. Blood 1998;92:1191-8.
  70. Hall CA, Begley JA, Green-Colligan PD. The availability of therapeutic hydroxocobalamin to cells. Blood 1984;63:335-41.
  71. Bolaman Z, Kadikoylu G, Yukselen V, Yavasoglu I, Barutca S, Senturk T. Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study. Clin Ther 2003;25:3124-34.
  72. Wang H, Li L, Qin LL, Song Y, Vidal-Alaball J, Liu TH. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev 2018;3:CD004655.
  73. Zerbe NF, Wagner BK. Use of vitamin B12 in the treatment and prevention of nitroprusside-induced cyanide toxicity. Crit Care Med 1993;21:465-7.
  74. Izumi Y, Kaji R. [Clinical trials of ultra-high-dose methylcobalamin in ALS]. Brain Nerve 2007;59:1141-7.
  75. Ashar YK, Chang LJ, Wager TD. Brain Mechanisms of the Placebo Effect: An Affective Appraisal Account. Annu Rev Clin Psychol 2017;13:73-98.
  76. Eussen SJ, de Groot LC, Joosten LW, et al. Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial. Am J Clin Nutr 2006;84:361-70.
  77. Almeida OP, Ford AH, Flicker L. Systematic review and meta-analysis of randomized placebo-controlled trials of folate and vitamin B12 for depression. Int Psychogeriatr 2015;27:727-37.
  78. Volkov I, Rudoy I, Freud T, et al. Effectiveness of vitamin B12 in treating recurrent aphthous stomatitis: a randomized, double-blind, placebo-controlled trial. J Am Board Fam Med 2009;22:9-16.
  79. Mauro GL, Martorana U, Cataldo P, Brancato G, Letizia G. Vitamin B12 in low back pain: a randomised, double-blind, placebo-controlled study. Eur Rev Med Pharmacol Sci 2000;4:53-8.